Navigation Links
First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin
Date:5/24/2011

opment. Powell's record of successful ventures includes the development of Sebastian, sold to P&G, and the growth of TIGI, sold to Unilever.

"Divine Skin is very fortunate to have Robin on our team," said Khesin. "Much of our current growth has come by leveraging his relationships."

About Divine Skin

Divine Skin Inc. is a biotechnology company engaged in the development of topical therapies and over-the-counter drugs that can be brought to market quickly, without lengthy regulatory requirements. In its consumer division, the company develops, markets, and distributes personal-care products through cosmetics wholesalers, online retailers, specialty outlets, spas, salons, and medical offices in more than 20 countries. Its brands include DS Laboratories, Sigma Skin, Polaris Research Laboratories, and The Pure Guild.

DS Laboratories, the flagship brand, offers high-performance topical solutions for men and women to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, maintain feminine hygiene, and reduce the appearance of cellulite, wrinkles, and double chins (www.dslaboratories.com).

The Sigma Skin brand targets men and sells through upscale retailers such as Bergdorf Goodman and Neiman Marcus in the United States, Saks Fifth Avenue in Mexico, and Harvey Nichols in the United Kingdom. Products are designed to reverse hair loss and other signs of aging (www.sigmaskin.com).

Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).

The Pure Guild, the newest brand, offers purity with performance. The botanical compounds proven most effective in rigorous clinical trials are extracted mechanically, using no industrial solvents or damaging heat. The uncompromised treatments sell through u
'/>"/>

SOURCE Divine Skin
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
2. Trubion Announces Dates for First-Quarter 2009 Earnings Conference Call
3. Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
4. Divine Skin Posts Record Sales for 2010: Up 55% Over 2009
5. WNDM Secures Additional International Sales; $150 K in New Orders for 2011
6. China-Biotics Receives First U.S. Sales Order
7. SeraCare Life Sciences Appoints Sean OConnor as Vice President of Sales and Marketing
8. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
9. Photonic Products Group, Inc. Announces New Sales and Marketing VP
10. Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
11. Content Management and Life Sciences Software Veteran Joins Virtify as Vice President of Worldwide Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   ... disease, announced today that the Company closed its ... Investment Management, Jack W. Schuler , Birchview ... were $10.5 million, before offering expenses.  The proceeds ...
(Date:12/24/2014)... 23, 2014 “Preparative & Process ... Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), ... Agriculture) - Forecasts to 2019” provides a detailed ... current market trends, and strategies impacting the preparative ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Earlier this year ... Sherley, director of the Adult Stem Cell Technology Center, LLC ... under appreciated unique property of adult tissue stem cells. ... the Past, Important for the Future,” embodied the essence of ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... Israel, April 7 InSightec Ltd. announced,today that the ... for the company,s ExAblate(R) 2000 MR-guided Focused Ultrasound,(MRgFUS) system ... Under the new labeling, the agency allows,physicians to treat ... previous,restriction to only treat up to half the fibroid ...
... -- China Sky One,Medical, Inc. ("China Sky One ... ), a,leading fully integrated pharmaceutical company producing,over-the-counter drugs ... that an extension notification filed with the Securities ... 10-K on March 31, 2009, is,related to a ...
... Filtration and Separations Society (AFS) will be holding its 22nd ... Minnesota. , ... Minneapolis, MN (PRWEB) April 7, 2009 ... be holding its 22nd Annual Conference, May 4-7, 2009 at the ...
Cached Biology Technology:FDA Approves Label Change for Non-Invasive Fibroid Treatment 2FDA Approves Label Change for Non-Invasive Fibroid Treatment 3China Sky One Medical, Inc. Provides Update on Filing Form 10-K 2China Sky One Medical, Inc. Provides Update on Filing Form 10-K 3University of Minnesota Professor Dr. David Pui to Speak at American Filtration and Separation Society Conference 2University of Minnesota Professor Dr. David Pui to Speak at American Filtration and Separation Society Conference 3
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication and ... Things era, today announced the close of $3 million ... by Metamorphic Ventures with participation from ENIAC Ventures, Crosslink ... LaunchKey has raised $4 million to date, and will ...
(Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has announced ... 2015-2019" report to their offering. ... upcoming in this market is the increasing demand for ... recording of patient data for quick and correct diagnosis ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... UCLA and a team of enterprising UCLA scientists envisioning a ... In 1996, a unique collaboration of leading UCLA scientists ... Inc. and the company now stands to reap $537 ... one of the largest Los Angeles-based private biotech firms poised ...
... gallons of hazardous waste resulting from the nations nuclear ... Washington state called Hanford. Beneath this desert landscape ... thousands of tons of chemicals are captured within the ... subsurface flow paths. These paths create uncertainties about ...
... making, Birds of Peru describes the birds of Peru ... in color, and concise descriptive text. The first two ... Douglas Stotz, PhD, are conservation ecologists and ornithologists in ... Museum will host a free public event launching the ...
Cached Biology News:Biotech Co. founded by UCLA Scientists to be acquired by Astellas, Pharma Inc. 2Biotech Co. founded by UCLA Scientists to be acquired by Astellas, Pharma Inc. 3Where does stored nuclear waste go? 2Lavishly illustrated guide to Peru's birds describes 1,800 species 2
...
Form: Concentrated Applications: ELISA...
Form: Ready to use Applications: ELISA...
Recombinant Mouse Serpin A1/alpha-1-Antitrypsin, CF Protein Family: Coagulation, Serine Protease Regulators...
Biology Products: